Countries: USA ▼

Tranxene T-Tab® Tablets (clorazepate dipotassium tablets, USP) 7.5mg Trade Notification Product Availability

09/23/2020

Download PDF

 

September 11th, 2020 (Update to Trade Letters dated February 19, 2020 and June 16, 2020)

 

Dear Trade Partner,

 

This is to inform you that a new lot of Tranxene T-Tab® Tablets (clorazepate dipotassium tablets, USP) 7.5mg, NDC 55292-304-01 presented as a 100Ct bottle with scored tablets has been successfully manufactured and will be released for distribution on Monday September 14, 2020. Cardinal Health SPS will be reaching out to all customers with open Tranxene orders starting on Monday.

 

As always, we greatly appreciate your business and your support. Should you have any questions, please contact info@recordatirarediseases.com.

 

Regards,

Michael Waters
General Manager

 

T-Tabs is a Registered Trademark of Recordati Rare Diseases Inc